Protocol for the Examination of Thyroid Gland Specimens



Protocol for the Examination of Thyroid Gland Specimens


Lester D. R. Thompson, MD
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Examination of Thyroid Gland Carcinoma Specimens



Resection


Procedure


_ _ _Thyroid lobectomy



_ _ _Right



_ _ _Left


_ _ _Partial thyroidectomy (anything less than a lobectomy)



_ _ _Right



_ _ _Left


_ _ _Total thyroidectomy


_ _ _Total thyroidectomy with central compartment dissection


_ _ _Total thyroidectomy with right neck dissection


_ _ _Total thyroidectomy with left neck dissection


_ _ _Total thyroidectomy with bilateral neck dissection


_ _ _Other (specify): _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _


_ _ _Not specified


* Received


* _ _ _Fresh


* _ _ _In formalin


* _ _ _Other


Specimen Integrity


_ _ _Intact


_ _ _Fragmented


Specimen Size



Right lobe: _ _ _ _ _ _ _ _ _ _ × _ _ _ _ _ _ _ _ _ _ × _ _ _ _ _ _ _ _ _ _ cm



Left lobe: _ _ _ _ _ _ _ _ _ _ × _ _ _ _ _ _ _ _ _ _ × _ _ _ _ _ _ _ _ _ _ cm



Isthmus ± pyramidal lobe: _ _ _ _ _ _ _ _ _ _ × _ _ _ _ _ _ _ _ _ _ × _ _ _ _ _ _ _ _ _ _ cm



Central compartment: _ _ _ _ _ _ _ _ _ _ × _ _ _ _ _ _ _ _ _ _ × _ _ _ _ _ _ _ _ _ _ cm



Right neck dissection: _ _ _ _ _ _ _ _ _ _ × _ _ _ _ _ _ _ _ _ _ × _ _ _ _ _ _ _ _ _ _ cm



Left neck dissection: _ _ _ _ _ _ _ _ _ _ × _ _ _ _ _ _ _ _ _ _ × _ _ _ _ _ _ _ _ _ _ cm



* Additional dimensions (specify): _ _ _ _ _ _ _ _ _ _ × _ _ _ _ _ _ _ _ _ _ × _ _ _ _ _ _ _ _ _ _ cm


* Specimen Weight



* Specify: _ _ _ _ _ _ _ _ _ _ g


Tumor Focality (select all that apply)


_ _ _Unifocal


_ _ _Multifocal (specify)



_ _ _Ipsilateral



_ _ _Bilateral



_ _ _Midline (isthmus)


Dominant Tumor



Tumor laterality




_ _ _Right lobe




_ _ _Left lobe




_ _ _Isthmus




_ _ _Not specified



Tumor size




Greatest dimension: _ _ _ _ _ _ _ _ _ _ cm




* Additional dimensions: _ _ _ _ _ _ _ _ _ _ × _ _ _ _ _ _ _ _ _ _ cm




_ _ _Cannot be determined



Histologic type (select all that apply)




_ _ _Papillary carcinoma





Variant, specify






_ _ _Classical (usual)






_ _ _Clear cell variant






_ _ _Columnar cell variant






_ _ _Cribriform-morular variant






_ _ _Diffuse sclerosing variant






_ _ _Follicular variant






_ _ _Macrofollicular variant






_ _ _Microcarcinoma (occult, latent, small, papillary microtumor)






_ _ _Oncocytic or oxyphilic variant






_ _ _Solid variant






_ _ _Tall cell variant






_ _ _Warthin-like variant






_ _ _Other (specify): _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _





Architecture






_ _ _Classical (papillary)






_ _ _Cribriform-morular






_ _ _Diffuse sclerosing






_ _ _Follicular






_ _ _Macrofollicular






_ _ _Solid






_ _ _Other (specify): _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _





Cytomorphology






_ _ _Classical






_ _ _Clear cell






_ _ _Columnar cell






_ _ _Oncocytic or oxyphilic






_ _ _Tall cell




_ _ _Follicular carcinoma





Variant, specify






_ _ _Clear cell






_ _ _Oncocytic (Hürthle cell)






_ _ _Other (specify): _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _




_ _ _Poorly differentiated thyroid carcinomas, including insular carcinoma




_ _ _Medullary carcinoma




_ _ _Undifferentiated (anaplastic) carcinoma




_ _ _Other (specify): _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _




_ _ _Carcinoma, type cannot be determined



* Histologic grade_ _ _




* _ _ _Not applicable




* _ _ _GX: Cannot be assessed




* _ _ _G1: Well differentiated




* _ _ _G2: Moderately differentiated




* _ _ _G3: Poorly differentiated




* _ _ _G4: Undifferentiated




* _ _ _Other (specify): _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _



Margins




_ _ _Cannot be assessed




_ _ _Margins uninvolved by carcinoma





* Distance of invasive carcinoma to closest margin: _ _ _ _ _ _ _ _ _ _ mm_ _ _




_ _ _Margin(s) involved by carcinoma





* Site(s) of involvement: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _



Tumor capsule




_ _ _Cannot be assessed




_ _ _Totally encapsulated




_ _ _Partially encapsulated




_ _ _None



Tumor capsular invasion




_ _ _Cannot be assessed




_ _ _Not identified




_ _ _Present





Extent





_ _ _Minimal





_ _ _Widely invasive





_ _ _Indeterminate



Lymph-vascular invasion




_ _ _Cannot be assessed




_ _ _Not identified




_ _ _Present





Extent





_ _ _Focal (< 4 vessels)





_ _ _Extensive (≥ 4 vessels)




_ _ _Indeterminate



* Perineural invasion




* _ _ _Not identified




* _ _ _Present




* _ _ _Indeterminate



Extrathyroidal extension




_ _ _Cannot be assessed




_ _ _Not identified




_ _ _Present





Extent





_ _ _Minimal





_ _ _Extensive


Second Tumor (for multifocal tumors only)



Tumor laterality (select all that apply)




_ _ _Right lobe




_ _ _Left lobe




_ _ _Isthmus




_ _ _Not specified



Tumor size




Greatest dimension: _ _ _ _ _ _ _ _ _ _ cm




* Additional dimensions: _ _ _ _ _ _ _ _ _ _ × _ _ _ _ _ _ _ _ _ _ cm




_ _ _Cannot be determined



Histologic type (select all that apply)



_ _ _Papillary carcinoma




Variant, specify





_ _ _Classical (usual)





_ _ _Clear cell variant





_ _ _Cribriform-morular variant





_ _ _Diffuse sclerosing variant





_ _ _Follicular variant





_ _ _Macrofollicular variant





_ _ _Microcarcinoma (occult, latent, small, papillary microtumor)





_ _ _Oncocytic or oxyphilic variant





_ _ _Solid variant





_ _ _Tall cell variant





_ _ _Warthin-like variant





_ _ _Other (specify): _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _





Architecture





_ _ _Classical (papillary)





_ _ _Cribriform-morular





_ _ _Diffuse sclerosing





_ _ _Follicular





_ _ _Macrofollicular





_ _ _Solid





_ _ _Other (specify): _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _





Cytomorphology





_ _ _Classical





_ _ _Clear cell





_ _ _Columnar cell





_ _ _Oncocytic or oxyphilic





_ _ _Tall cell




_ _ _Follicular carcinoma





Variant, specify





_ _ _Clear cell





_ _ _Oncocytic (Hürthle cell)





_ _ _Other (specify): _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _




_ _ _Poorly differentiated thyroid carcinomas, including insular carcinoma




_ _ _Medullary carcinoma




_ _ _Undifferentiated (anaplastic) carcinoma




_ _ _Other (specify): _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _




_ _ _Carcinoma, type cannot be determined



* Histologic grade




* _ _ _Not applicable




* _ _ _GX: Cannot be assessed




* _ _ _G1: Well differentiated




* _ _ _G2: Moderately differentiated




* _ _ _G3: Poorly differentiated




* _ _ _G4: Undifferentiated




* _ _ _Other (specify): _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _



Margins




_ _ _Cannot be assessed




_ _ _Totally encapsulated




_ _ _Partially encapsulated




_ _ _None



Tumor capsular invasion




_ _ _Cannot be assessed




_ _ _Not identified




_ _ _Present





Extent





_ _ _Minimally





_ _ _Widely invasive




_ _ _Indeterminate



Lymph-vascular invasion




_ _ _Cannot be assessed




_ _ _Not identified




_ _ _Present





Extent





_ _ _Focal (< 4 vessels)





_ _ _Extensive (≥ 4 vessels)




_ _ _Indeterminate



* Perineural invasion




* _ _ _Not identified




* _ _ _Present




* _ _ _Indeterminate



Extrathyroidal extension




_ _ _Cannot be assessed




_ _ _Not identified




_ _ _Present





Extent





_ _ _Minimal





_ _ _Extensive


Pathologic Staging (pTNM)



TNM descriptors (required only if applicable) (select all that apply)




_ _ _m (multiple primary tumors)




_ _ _r (recurrent)




_ _ _y (post-treatment)



Primary tumor (pT)†




_ _ _pTX: Cannot be assessed




_ _ _pT0: No evidence of primary tumor




_ _ _pT1: Tumor size ≤ 2 cm, limited to thyroid





_ _ _pT1a: Tumor ≤ 1 cm in greatest dimension, limited to thyroid





_ _ _pT1b: Tumor > 1 cm but ≤ 2 cm in greatest dimension, limited to thyroid




_ _ _pT2: Tumor > 2 cm, but ≤ 4 cm, limited to thyroid




_ _ _pT3: Tumor > 4 cm limited to thyroid, or any tumor with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues)




_ _ _pT4a: Moderately advanced disease.






Tumor of any size extending beyond thyroid capsule to invade subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve




_ _ _pT4b: Very advanced disease. Tumor invades prevertebral fascia or encases carotid artery or mediastinal vessels



Undifferentiated (anaplastic) carcinoma




_ _ _pT4a: Intrathyroidal undifferentiated carcinoma, surgically resectable




_ _ _pT4b: Extrathyroidal undifferentiated carcinoma, surgically unresectable



Regional lymph nodes (pN)††




_ _ _pNX: Cannot be assessed




_ _ _pN0: No regional lymph node metastasis




_ _ _pN1a: Nodal metastases to level VI (pretracheal, paratracheal, and prelaryngeal/Delphian) lymph nodes




_ _ _pN1b: Metastases to unilateral, bilateral, or contralateral cervical (levels I, II, III, IV, V)






or retropharyngeal or superior mediastinal lymph nodes (level VII)






Specify: Number examined: _ _ _ _ _ _ _ _ _ _







Number involved: _ _ _ _ _ _ _ _ _ _



* Lymph node, extranodal extension




* _ _ _Not identified




* _ _ _Present




* _ _ _Indeterminate



Distant metastasis (pM)



_ _ _Not applicable



_ _ _pM1: Distant metastasis





* Specify site(s), if known: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _





* Source of pathologic metastatic specimen (specify): _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _


* Additional Pathologic Findings (select all that apply)


* _ _ _Adenoma


* _ _ _Adenomatoid nodule(s) or nodular follicular disease (e.g., nodular hyperplasia, goitrous thyroid)


* _ _ _Diffuse hyperplasia (Graves disease)


* _ _ _Thyroiditis



* _ _ _Advanced



* _ _ _Focal (nonspecific)



* _ _ _Palpation



* _ _ _Other (specify): _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _


* _ _ _Parathyroid gland(s)



* _ _ _Within normal limits



* _ _ _Hypercellular



* _ _ _Other (specify): _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _


* _ _ _C-cell hyperplasia


* _ _ _Other (specify): _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _


* _ _ _None identified


* Ancillary Studies



* Specify type (e.g., histochemistry, immunohistochemistry, DNA analysis): _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _



* Specify results: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _


* Clinical History (select all that apply)


* _ _ _Radiation exposure



* _ _ _Yes (specify type): _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _



* _ _ _No



* _ _ _Indeterminate


* _ _ _Family history


* _ _ _Other (specify): _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _


* Data elements with asterisks are not required. However, these elements may be clinically important but are not yet validated or regularly used in patient management. †Note: There is no category of carcinoma in situ (pTis) relative to carcinomas of thyroid gland. ††Superior mediastinal lymph nodes are considered regional lymph nodes (level VII). Midline nodes are considered ipsilateral nodes. Adapted with permission from College of American Pathologists, “Protocol for the Examination of Specimens from Patients with Carcinoma of the Thyroid Gland.” Web posting date October 2009, www.cap.org.



Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 7, 2016 | Posted by in PATHOLOGY & LABORATORY MEDICINE | Comments Off on Protocol for the Examination of Thyroid Gland Specimens

Full access? Get Clinical Tree

Get Clinical Tree app for offline access